KLBF:IDX
Kalbe Farma Tbk PT
IDR 780.00
arrow_upward
+1.96%(+15.00) 1D
Oct 13, 4:12:15 PM GMT+7 · IDR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KLBF...
Open
IDR 770
High
IDR 780
Low
IDR 755
Mkt. cap
36.51T
Avg. vol.
66.50M
Volume
37.55M
Dividend
2.56%
Quarterly dividend
IDR 5
Ex-dividend date
Jun 4, 2026
P/E ratio
9.80
52-wk high
IDR 1,345
52-wk low
IDR 630
EPS
IDR 80
Shares outstanding
46.81B
No. of employees
13K
Open
IDR 770
High
IDR 780
Low
IDR 755
Mkt. cap
36.51T
Avg. vol.
66.50M
Volume
37.55M
Dividend
2.56%
Quarterly dividend
IDR 5
Ex-dividend date
Jun 4, 2026
P/E ratio
9.80
52-wk high
IDR 1,345
52-wk low
IDR 630
EPS
IDR 80
Shares outstanding
46.81B
No. of employees
13K
News stories
From web sources and news partners
MarketForces Africa
·
17 minutes ago
European Stocks Rally As AI Bears Drag S&P 500, Nasdaq Lower
TradingView
·
32 minutes ago
S&P 500 futures muted as investors await big bank earnings; chip weakness weighs
Inc.com
·
1 hour ago
The S&P 500’s Bull Market Just Turned 4. History Says the Next Year Is What Matters Most
Action Forex
·
2 hours ago
Dow Jones Index Wave Analysis
Profile
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
About Kalbe Farma Tbk PT